Published in Proc Natl Acad Sci U S A on March 01, 1989
The rule of six, a basic feature for efficient replication of Sendai virus defective interfering RNA. J Virol (1993) 6.38
A general purpose RNA-cleaving DNA enzyme. Proc Natl Acad Sci U S A (1997) 6.02
Ribozymes, riboswitches and beyond: regulation of gene expression without proteins. Nat Rev Genet (2007) 2.52
'Hairpin' catalytic RNA model: evidence for helices and sequence requirement for substrate RNA. Nucleic Acids Res (1990) 2.38
The self-cleaving domain from the genomic RNA of hepatitis delta virus: sequence requirements and the effects of denaturant. Nucleic Acids Res (1990) 2.20
Characterization of hepatitis delta antigen: specific binding to hepatitis delta virus RNA. J Virol (1990) 2.17
Expression of hepatitis delta virus RNA deletions: cis and trans requirements for self-cleavage, ligation, and RNA packaging. J Virol (1994) 1.93
Evidence that genomic and antigenomic RNA self-cleaving elements from hepatitis delta virus have similar secondary structures. Nucleic Acids Res (1991) 1.63
RNA-binding activity of hepatitis delta antigen involves two arginine-rich motifs and is required for hepatitis delta virus RNA replication. J Virol (1993) 1.57
Efficient trans cleavage and a common structural motif for the ribozymes of the human hepatitis delta agent. Proc Natl Acad Sci U S A (1991) 1.53
Core sequences and a cleavage site wobble pair required for HDV antigenomic ribozyme self-cleavage. Nucleic Acids Res (1996) 1.39
A nested double pseudoknot is required for self-cleavage activity of both the genomic and antigenomic hepatitis delta virus ribozymes. RNA (1999) 1.39
Replication of hepatitis delta virus RNA: effect of mutations of the autocatalytic cleavage sites. J Virol (1993) 1.34
Specific association between an endoribonucleolytic sequence from a satellite RNA and a substrate analogue containing a 2'-5' phosphodiester. Proc Natl Acad Sci U S A (1990) 1.31
RNA conformational requirements of self-cleavage of hepatitis delta virus RNA. Mol Cell Biol (1990) 1.30
A circular trans-acting hepatitis delta virus ribozyme. Nucleic Acids Res (1993) 1.27
Paramyxovirus mRNA editing leads to G deletions as well as insertions. EMBO J (1994) 1.27
Mutagenesis analysis of the self-cleavage domain of hepatitis delta virus antigenomic RNA. Nucleic Acids Res (1992) 1.25
A pseudoknot ribozyme structure is active in vivo and required for hepatitis delta virus RNA replication. J Virol (1996) 1.25
Functional motifs of delta antigen essential for RNA binding and replication of hepatitis delta virus. J Virol (1993) 1.21
RNA replication without RNA-dependent RNA polymerase: surprises from hepatitis delta virus. J Virol (2005) 1.21
RNA-mediated ligation of self-cleavage products of a Neurospora mitochondrial plasmid transcript. Proc Natl Acad Sci U S A (1991) 1.19
Searching genomes for ribozymes and riboswitches. Genome Biol (2007) 1.19
Intrahepatic genetic inoculation of hepatitis C virus RNA confers cross-protective immunity. J Virol (2001) 1.17
Non-ribozyme sequences enhance self-cleavage of ribozymes derived from Hepatitis delta virus. Nucleic Acids Res (1991) 1.16
Rescue of recombinant Marburg virus from cDNA is dependent on nucleocapsid protein VP30. J Virol (2006) 1.15
Random mutations to evaluate the role of bases at two important single-stranded regions of genomic HDV ribozyme. Nucleic Acids Res (1992) 1.14
Inhibition of HIV-1 replication by ribozymes that show poor activity in vitro. Nucleic Acids Res (1993) 1.14
The folding of the hairpin ribozyme: dependence on the loops and the junction. RNA (2000) 1.13
HDV-like self-cleaving ribozymes. RNA Biol (2011) 1.12
Ribozyme-based gene-inactivation systems require a fine comprehension of their substrate specificities; the case of delta ribozyme. Curr Med Chem (2003) 1.10
Hepatitis delta antigens enhance the ribozyme activities of hepatitis delta virus RNA in vivo. J Virol (1996) 1.09
Substrate specificity of delta ribozyme cleavage. J Biol Chem (1998) 1.09
Nuclear localization signals, but not putative leucine zipper motifs, are essential for nuclear transport of hepatitis delta antigen. J Virol (1992) 1.07
From alpaca to zebrafish: hammerhead ribozymes wherever you look. RNA (2010) 1.07
Alternative modes of self-cleavage by newt satellite 2 transcripts. Nucleic Acids Res (1991) 1.07
Alternative hammerhead structures in the self-cleavage of avocado sunblotch viroid RNAs. Nucleic Acids Res (1991) 1.06
Folding of the HDV antigenomic ribozyme pseudoknot structure deduced from long-range photocrosslinks. Nucleic Acids Res (1996) 1.05
Complete nucleotide sequence of hepatitis delta virus RNA in Japan. Nucleic Acids Res (1991) 1.05
Deletion of internal sequence on the HDV-ribozyme: elucidation of functionally important single-stranded loop regions. Nucleic Acids Res (1992) 1.04
Isoprenylation masks a conformational epitope and enhances trans-dominant inhibitory function of the large hepatitis delta antigen. J Virol (1994) 1.03
Identification of phosphate oxygens that are important for self-cleavage activity of the HDV ribozyme by phosphorothioate substitution interference analysis. Nucleic Acids Res (1994) 1.03
Ribozymes which cleave arenavirus RNAs: identification of susceptible target sites and inhibition by target site secondary structure. J Virol (1992) 1.03
Requirement for canonical base pairing in the short pseudoknot structure of genomic hepatitis delta virus ribozyme. Nucleic Acids Res (2000) 1.02
Ribozyme cleavage of a 2,5-phosphodiester linkage: mechanism and a restricted divalent metal-ion requirement. RNA (1999) 1.02
A versatile communication module for controlling RNA folding and catalysis. Nucleic Acids Res (2002) 1.02
Assessment of disparate structural features in three models of the hepatitis delta virus ribozyme. Nucleic Acids Res (1993) 1.01
Mutational analysis of delta antigen: effect on assembly and replication of hepatitis delta virus. J Virol (1994) 1.01
Self-cleavage of a 71 nucleotide-long ribozyme derived from hepatitis delta virus genomic RNA. Nucleic Acids Res (1991) 1.01
Formation of the P1.1 pseudoknot is critical for both the cleavage activity and substrate specificity of an antigenomic trans-acting hepatitis delta ribozyme. Nucleic Acids Res (2003) 1.00
Chemistry and Biology of Self-Cleaving Ribozymes. Trends Biochem Sci (2015) 1.00
Chemical rescue, multiple ionizable groups, and general acid-base catalysis in the HDV genomic ribozyme. RNA (2006) 0.99
Mutagenesis analysis of a hepatitis delta virus genomic ribozyme. Nucleic Acids Res (1993) 0.99
Transgenic mice support replication of hepatitis delta virus RNA in multiple tissues, particularly in skeletal muscle. J Virol (1995) 0.99
Characterization of the Structure and Dynamics of the HDV Ribozyme at Different Stages Along the Reaction Path. J Phys Chem Lett (2011) 0.98
Prominent polypurine and polypyrimidine tracts in plant viroids and in RNA of the human hepatitis delta agent. Nucleic Acids Res (1993) 0.97
Large hepatitis delta antigen in packaging and replication inhibition: role of the carboxyl-terminal 19 amino acids and amino-terminal sequences. J Virol (1995) 0.95
Structure-based search reveals hammerhead ribozymes in the human microbiome. J Biol Chem (2011) 0.95
Functional domains of delta antigens and viral RNA required for RNA packaging of hepatitis delta virus. J Virol (1995) 0.95
Metal ions: supporting actors in the playbook of small ribozymes. Met Ions Life Sci (2011) 0.93
Detailed analysis of base preferences at the cleavage site of a trans-acting HDV ribozyme: a mutation that changes cleavage site specificity. Nucleic Acids Res (1997) 0.93
Polyadenylation of the mRNA of hepatitis delta virus is dependent on the structure of the nascent RNA and regulated by the small or large delta antigen. Nucleic Acids Res (1994) 0.90
The structure of the isolated, central hairpin of the HDV antigenomic ribozyme: novel structural features and similarity of the loop in the ribozyme and free in solution. EMBO J (1997) 0.89
3-D models of the antigenomic ribozyme of the hepatitis delta agent with eight new contacts suggested by sequence analysis of 188 cDNA clones. Nucleic Acids Res (1995) 0.88
X-ray crystallographic observation of "in-line" and "adjacent" conformations in a bulged self-cleaving RNA/DNA hybrid. RNA (2001) 0.88
Energetic contribution of non-essential 5' sequence to catalysis in a hepatitis delta virus ribozyme. EMBO J (2001) 0.88
The human HDV-like CPEB3 ribozyme is intrinsically fast-reacting. Biochemistry (2010) 0.87
Computational discovery of folded RNA domains in genomes and in vitro selected libraries. Methods (2010) 0.87
ERK1/2-mediated phosphorylation of small hepatitis delta antigen at serine 177 enhances hepatitis delta virus antigenomic RNA replication. J Virol (2008) 0.86
Development of an isoform-specific gene suppression system: the study of the human Pax-5B transcriptional element. Nucleic Acids Res (2008) 0.84
Core-associated non-duplex sequences distinguishing the genomic and antigenomic self-cleaving RNAs of hepatitis delta virus. Nucleic Acids Res (1997) 0.83
An RNA tertiary structure of the hepatitis delta agent contains UV-sensitive bases U-712 and U-865 and can form in a bimolecular complex. Nucleic Acids Res (1995) 0.83
Specific RNA self-cleavage in coconut cadang cadang viroid: potential for a role in rolling circle replication. RNA (1998) 0.83
The structure of the L3 loop from the hepatitis delta virus ribozyme: a syn cytidine. Nucleic Acids Res (1998) 0.83
Hepatitis delta virus: insights into a peculiar pathogen and novel treatment options. Nat Rev Gastroenterol Hepatol (2016) 0.82
Catalytic nucleic acid enzymes for the study and development of therapies in the central nervous system: Review Article. Gene Ther Mol Biol (2005) 0.82
RNA recombination of hepatitis delta virus in natural mixed-genotype infection and transfected cultured cells. J Virol (2005) 0.82
New tools provide a second look at HDV ribozyme structure, dynamics and cleavage. Nucleic Acids Res (2014) 0.81
Inactivation of Tetrahymena rRNA self-splicing by cis-platin proceeds through dissociable complexes. Nucleic Acids Res (1991) 0.80
Tm studies of a tertiary structure from the human hepatitis delta agent which functions in vitro as a ribozyme control element. Nucleic Acids Res (1995) 0.79
Enzymatic incorporation of 2'-thio-CTP into the HDV ribozyme. RNA (1998) 0.79
Riboswitch-mediated Attenuation of Transgene Cytotoxicity Increases Adeno-associated Virus Vector Yields in HEK-293 Cells. Mol Ther (2015) 0.77
Single substitutions of phosphorothioates in the HDV ribozyme G73 define regions necessary for optimal self-cleaving activity. Nucleic Acids Res (1997) 0.77
Assessment of metal-assisted nucleophile activation in the hepatitis delta virus ribozyme from molecular simulation and 3D-RISM. RNA (2015) 0.76
A Two-Metal-Ion-Mediated Conformational Switching Pathway for HDV Ribozyme Activation. ACS Catal (2016) 0.75
Viral hepatitis. Gut (1991) 0.75
Hepatology. Postgrad Med J (1991) 0.75
Direct acting antivirals for the treatment of chronic viral hepatitis. Scientifica (Cairo) (2012) 0.75
Ribozyme-enhanced single-stranded Ago2-processed interfering RNA triggers efficient gene silencing with fewer off-target effects. Nat Commun (2015) 0.75
Hepatitis Delta Virus: Replication Strategy and Upcoming Therapeutic Options for a Neglected Human Pathogen. Viruses (2017) 0.75
Analyses of a whole-genome inter-clade recombination map of hepatitis delta virus suggest a host polymerase-driven and viral RNA structure-promoted template-switching mechanism for viral RNA recombination. Oncotarget (2017) 0.75
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
Optimal computer folding of large RNA sequences using thermodynamics and auxiliary information. Nucleic Acids Res (1981) 61.59
A bacteriophage T7 RNA polymerase/promoter system for controlled exclusive expression of specific genes. Proc Natl Acad Sci U S A (1985) 46.59
A small catalytic oligoribonucleotide. Nature (1987) 8.73
Self-cleavage of plus and minus RNAs of a virusoid and a structural model for the active sites. Cell (1987) 8.19
Specific labeling of 3' termini of RNA with T4 RNA ligase. Methods Enzymol (1980) 7.55
Structure, sequence and expression of the hepatitis delta (delta) viral genome. Nature (1986) 7.38
Autolytic processing of dimeric plant virus satellite RNA. Science (1986) 6.14
Structure and replication of the genome of the hepatitis delta virus. Proc Natl Acad Sci U S A (1986) 5.23
A replication cycle for viroids and other small infectious RNA's. Science (1984) 5.18
Molecular cloning of hepatitis delta virus RNA from an infected woodchuck liver: sequence, structure, and applications. J Virol (1988) 4.96
Antigenomic RNA of human hepatitis delta virus can undergo self-cleavage. J Virol (1988) 4.59
Molecular cloning and sequencing of a human hepatitis delta (delta) virus RNA. Nature (1987) 4.52
Characterization of self-cleaving RNA sequences on the genome and antigenome of human hepatitis delta virus. J Virol (1988) 4.05
The hepatitis delta (delta) virus possesses a circular RNA. Nature (1986) 4.00
Self-cleaving transcripts of satellite DNA from the newt. Cell (1987) 3.37
Satellite tobacco ringspot virus RNA: A subset of the RNA sequence is sufficient for autolytic processing. Proc Natl Acad Sci U S A (1986) 3.24
Human hepatitis delta antigen is a nuclear phosphoprotein with RNA-binding activity. J Virol (1988) 3.11
Infectivity and in vitro mutagenesis of monomeric cDNA clones of citrus exocortis viroid indicates the site of processing of viroid precursors. Nucleic Acids Res (1985) 2.03
Reversible cleavage and ligation of hepatitis delta virus RNA. Science (1989) 1.59
Viroid processing: a model involving the central conserved region and hairpin I. Proc Natl Acad Sci U S A (1986) 1.49
Continuous tissue culture cell lines derived from chemically induced tumors of Japanese quail. Cell (1977) 7.23
Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. Science (1999) 6.21
Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu (1980) 5.03
A genetic determinant required for continuous reinfection of adjacent cells on large plasmid in S. flexneri 2a. Cell (1986) 4.88
DOCK 4.0: search strategies for automated molecular docking of flexible molecule databases. J Comput Aided Mol Des (2001) 4.54
Molecular cloning and sequencing of a human hepatitis delta (delta) virus RNA. Nature (1987) 4.52
Adenylic acid-rich sequence in RNAs of Rous sarcoma virus and Rauscher mouse leukaemia virus. Nature (1972) 4.49
Molecular alteration of the 140-megadalton plasmid associated with loss of virulence and Congo red binding activity in Shigella flexneri. Infect Immun (1986) 4.33
RNA of mouse hepatitis virus. J Virol (1978) 4.27
The complete sequence (22 kilobases) of murine coronavirus gene 1 encoding the putative proteases and RNA polymerase. Virology (1991) 4.07
Mouse hepatitis virus A59: mRNA structure and genetic localization of the sequence divergence from hepatotropic strain MHV-3. J Virol (1981) 4.00
Characterization of leader RNA sequences on the virion and mRNAs of mouse hepatitis virus, a cytoplasmic RNA virus. Proc Natl Acad Sci U S A (1984) 3.81
Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci (1995) 3.56
Avian tumor virus RNA: a comparison of three sarcoma viruses and their transformation-defective derivatives by oligonucleotide fingerprinting and DNA-RNA hybridization. Proc Natl Acad Sci U S A (1973) 3.46
Ribonucleic acid components of murine sarcoma and leukemia viruses. Proc Natl Acad Sci U S A (1973) 3.42
Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology (2001) 3.40
virG, a plasmid-coded virulence gene of Shigella flexneri: identification of the virG protein and determination of the complete coding sequence. J Bacteriol (1989) 3.31
Virulence-associated genetic regions comprising 31 kilobases of the 230-kilobase plasmid in Shigella flexneri 2a. J Bacteriol (1988) 3.24
Human hepatitis delta antigen is a nuclear phosphoprotein with RNA-binding activity. J Virol (1988) 3.11
The NOD mouse: recessive diabetogenic gene in the major histocompatibility complex. Science (1986) 3.09
Presence of leader sequences in the mRNA of mouse hepatitis virus. J Virol (1983) 3.06
High-frequency RNA recombination of murine coronaviruses. J Virol (1986) 2.91
Replication of mouse hepatitis virus: negative-stranded RNA and replicative form RNA are of genome length. J Virol (1982) 2.86
A dual transcriptional activation system for the 230 kb plasmid genes coding for virulence-associated antigens of Shigella flexneri. Mol Microbiol (1989) 2.81
The murine autoimmune diabetes model: NOD and related strains. Adv Immunol (1992) 2.80
Characterization of replicative intermediate RNA of mouse hepatitis virus: presence of leader RNA sequences on nascent chains. J Virol (1983) 2.80
Early dexamethasone therapy in preterm infants: a follow-up study. Pediatrics (1998) 2.65
Circadian waves of expression of the APRR1/TOC1 family of pseudo-response regulators in Arabidopsis thaliana: insight into the plant circadian clock. Plant Cell Physiol (2000) 2.61
Characterization of two RNA polymerase activities induced by mouse hepatitis virus. J Virol (1982) 2.46
Molecular characterization of proteins in detergent solutions. Biochemistry (1974) 2.36
The 3'-untranslated region of hepatitis C virus RNA enhances translation from an internal ribosomal entry site. J Virol (1998) 2.36
Further characterization of mRNA's of mouse hepatitis virus: presence of common 5'-end nucleotides. J Virol (1982) 2.34
Hepatitis C virus RNA polymerase and NS5A complex with a SNARE-like protein. Virology (1999) 2.33
Airway hyperresponsiveness, increased intracellular spaces of bronchial epithelium, and increased infiltration of eosinophils and lymphocytes in bronchial mucosa in asthma. Am Rev Respir Dis (1992) 2.30
Comparative analysis of RNA genomes of mouse hepatitis viruses. J Virol (1981) 2.30
Restriction enzyme sites on the avian RNA tumor virus genome. J Virol (1978) 2.29
Determination of the secondary structure of and cellular protein binding to the 3'-untranslated region of the hepatitis C virus RNA genome. J Virol (1997) 2.28
Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis. J Virol (1998) 2.28
DNA sequence and product analysis of the virF locus responsible for congo red binding and cell invasion in Shigella flexneri 2a. Infect Immun (1986) 2.22
Occurrence of partial deletion and substitution of the src gene in the RNA genome of avian sarcoma virus. Proc Natl Acad Sci U S A (1977) 2.22
Recombination between nonsegmented RNA genomes of murine coronaviruses. J Virol (1985) 2.21
The 5'-end sequence of the murine coronavirus genome: implications for multiple fusion sites in leader-primed transcription. Virology (1987) 2.17
Characterization of hepatitis delta antigen: specific binding to hepatitis delta virus RNA. J Virol (1990) 2.17
A recombinant hepatitis C virus RNA-dependent RNA polymerase capable of copying the full-length viral RNA. J Virol (1999) 2.16
Leader sequences of murine coronavirus mRNAs can be freely reassorted: evidence for the role of free leader RNA in transcription. Proc Natl Acad Sci U S A (1986) 2.16
Analysis of genomic and intracellular viral RNAs of small plaque mutants of mouse hepatitis virus, JHM strain. Virology (1984) 2.13
Antigenic relationships of murine coronaviruses: analysis using monoclonal antibodies to JHM (MHV-4) virus. Virology (1983) 2.11
Structure of the intracellular defective viral RNAs of defective interfering particles of mouse hepatitis virus. J Virol (1985) 2.10
Promotion of spontaneous diabetes in non-obese diabetes-prone mice by cyclophosphamide. Diabetologia (1984) 2.07
Phosphoproteins of murine hepatitis viruses. J Virol (1979) 2.07
Characterization of leader-related small RNAs in coronavirus-infected cells: further evidence for leader-primed mechanism of transcription. Virus Res (1985) 2.07
Molecular cloning of a genetic determinant for Congo red binding ability which is essential for the virulence of Shigella flexneri. Infect Immun (1986) 2.05
Identification and characterization of a coronavirus packaging signal. J Virol (1992) 2.01
Identification of a novel gene, dep, associated with depolymerization of the capsular polymer in Bacillus anthracis. Mol Microbiol (1993) 1.96
High-frequency leader sequence switching during coronavirus defective interfering RNA replication. J Virol (1989) 1.95
Double termination of the alimentary tract in females: a report of 12 cases and a literature review. J Pediatr Surg (1984) 1.90
An internal polypyrimidine-tract-binding protein-binding site in the hepatitis C virus RNA attenuates translation, which is relieved by the 3'-untranslated sequence. Virology (1999) 1.90
Characterization of the coronavirus M protein and nucleocapsid interaction in infected cells. J Virol (2000) 1.89
Sequence and translation of the murine coronavirus 5'-end genomic RNA reveals the N-terminal structure of the putative RNA polymerase. J Virol (1987) 1.89
Analysis of cis-acting sequences essential for coronavirus defective interfering RNA replication. Virology (1993) 1.89
Analysis of efficiently packaged defective interfering RNAs of murine coronavirus: localization of a possible RNA-packaging signal. J Virol (1990) 1.88
Primary structure and translation of a defective interfering RNA of murine coronavirus. Virology (1988) 1.87
Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-beta receptor. J Virol (1997) 1.84
Identification of a domain required for autoproteolytic cleavage of murine coronavirus gene A polyprotein. J Virol (1989) 1.82
Isolation, characterization, and mapping of Tn5 insertions into the 140-megadalton invasion plasmid defective in the mouse Sereny test in Shigella flexneri 2a. Infect Immun (1986) 1.81
The binding of deoxycholate and Triton X-100 to proteins. J Biol Chem (1973) 1.81
Nucleotide sequence and expression in Escherichia coli of the gene coding for sphingomyelinase of Bacillus cereus. Eur J Biochem (1988) 1.80
Unique functions of Sonic hedgehog signaling during external genitalia development. Development (2001) 1.80
A gene (sleB) encoding a spore cortex-lytic enzyme from Bacillus subtilis and response of the enzyme to L-alanine-mediated germination. J Bacteriol (1996) 1.79
Identification of a new transcriptional initiation site and the corresponding functional gene 2b in the murine coronavirus RNA genome. J Virol (1989) 1.77
Defective interfering particles of mouse hepatitis virus. Virology (1984) 1.76
Discontinuous transcription generates heterogeneity at the leader fusion sites of coronavirus mRNAs. J Virol (1988) 1.76
Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. J Virol (1992) 1.75
Identification of the catalytic sites of a papain-like cysteine proteinase of murine coronavirus. J Virol (1993) 1.74
Clinical significance of bronchial sensitivity to acetylcholine and histamine in bronchial asthma. J Allergy (1966) 1.73
Differential subcellular localization of hepatitis C virus core gene products. Virology (1995) 1.73
Defective-interfering particles of murine coronavirus: mechanism of synthesis of defective viral RNAs. Virology (1988) 1.73
Deletion mapping of a mouse hepatitis virus defective interfering RNA reveals the requirement of an internal and discontiguous sequence for replication. J Virol (1993) 1.71
Heterogeneous nuclear ribonucleoprotein A1 binds to the transcription-regulatory region of mouse hepatitis virus RNA. Proc Natl Acad Sci U S A (1997) 1.70
An in vitro system for the leader-primed transcription of coronavirus mRNAs. EMBO J (1990) 1.69
Genome of avian myelocytomatosis virus MC29: analysis by heteroduplex mapping. Proc Natl Acad Sci U S A (1979) 1.68
Phosphoproteins of Rous sarcoma viruses. Virology (1976) 1.67
Colocalization and membrane association of murine hepatitis virus gene 1 products and De novo-synthesized viral RNA in infected cells. J Virol (1999) 1.67
Differences between the envelope glycoproteins and glycopeptides of avian tumor viruses released from transformed and from nontransformed cells. Virology (1972) 1.67
Archaeal adaptation to higher temperatures revealed by genomic sequence of Thermoplasma volcanium. Proc Natl Acad Sci U S A (2000) 1.67
Tumor-related leukocytosis is linked with poor prognosis in patients with lung carcinoma. Cancer (2001) 1.65